- 期刊
Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease
延伸閱讀
- Chang, W. Y., & Lin, Z. Y. (1990). Serum B Protein in Hepatocellular Carcinoma and Liver Cirrhosis. The Kaohsiung Journal of Medical Sciences, 6(11), 599-605. https://doi.org/10.6452/KJMS.199011.0599
- Yang, H. I. (2006). Hepatitis B Virus Related Factors and the Risks of Liver Cirrhosis and Hepatocellular Carcinoma [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2006.02389
- 黃正昌、朱辨弦、吳政億、郭興伯、潘念宗（2011）。Treatment of Chronic Hepatitis B with Surface Antigen Change to Negative and Clinical Analysis of Case Reports。中醫藥研究論叢，14(2)，65-78。https://doi.org/10.6516/TJTCM.201109_14(2).0006
- Michitaka, K., Hiraoka, A., Tokumoto, Y., Ninomiya, K., Ninomiya, T., Horiike, N., Abe, M., & Hiasa, Y. (2014). Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic Infection. International Journal of Hepatology, (2014), c1-5. https://doi.org/10.1155/2014/358206
- Lin, S., Sun, Q., Mao, W., & Chen, Y. (2016). Serum Immunoglobulin A (IgA) Level Is a Potential Biomarker Indicating Cirrhosis during Chronic Hepatitis B Infection. Gastroenterology Research and Practice, 2016(), 344-349-044. https://doi.org/10.1155/2016/2495073